logo
#

Latest news with #Horizon2020

Europe Personalized Medicine Biomarkers Market Trends and Forecast Report 2025-2032, Competitive Analysis of Thermo Fisher Scientific, Illumina, Bio-Rad Laboratories, Roche, Guardant Health
Europe Personalized Medicine Biomarkers Market Trends and Forecast Report 2025-2032, Competitive Analysis of Thermo Fisher Scientific, Illumina, Bio-Rad Laboratories, Roche, Guardant Health

Yahoo

time20-05-2025

  • Business
  • Yahoo

Europe Personalized Medicine Biomarkers Market Trends and Forecast Report 2025-2032, Competitive Analysis of Thermo Fisher Scientific, Illumina, Bio-Rad Laboratories, Roche, Guardant Health

Germany leads the market with substantial R&D investments and a favorable regulatory environment. Institutions like the German Cancer Research Center and initiatives such as the National Genome Research Network support this growth. Other major markets, including France, the U.K., Italy, and Spain, are also heavily investing in personalized medicine. Dublin, May 20, 2025 (GLOBE NEWSWIRE) -- The "Europe Personalized Medicine Biomarkers Market - Industry Analysis, Size, Share, Growth, Trends, and Forecast 2032 - By Product, Technology, Grade, Application, End-user, Region: (Europe)" has been added to offering. The Europe personalized medicine biomarkers market is on a trajectory of remarkable expansion as the region embraces innovations in genomics, biotechnology, and diagnostic science. With a rising demand for precision therapies tailored to individual patients, especially in oncology and genetic disorders, the market is projected to reach US$ 6.47 billion in 2025, surging to US$ 18.3 billion by 2032 at a CAGR of 16.01%. Personalized medicine biomarkers are transforming clinical decision-making, enabling healthcare providers to diagnose conditions earlier, predict disease progression, and customize treatment strategies. Across Europe, initiatives like Horizon 2020 and EIP-AHA are fostering a research-friendly environment. The integration of next-generation sequencing and non-invasive liquid biopsy technologies is enhancing the precision and scope of personalized medicine. Key Market Drivers Growing Demand for Targeted Therapies: The market is witnessing a heightened interest in therapies that provide improved efficacy by targeting specific molecular pathways, boosting the need for biomarker-based diagnostics. Surge in Non-Invasive Liquid Biopsy Adoption: These minimally invasive tests detect disease markers in blood, revolutionizing cancer diagnostics and enabling early detection. Policy Support and Research Funding: European regulatory and funding bodies are strongly backing the development of personalized medicine, propelling biomarker innovation. Technological Advancements in Genomics: Breakthroughs in CRISPR gene-editing, single-cell RNA sequencing, and AI are expanding the boundaries of biomarker development. Business Opportunities Advanced Genomic Solutions for Differentiation: Companies that adopt cutting-edge genomic technologies can capture greater market share with AI-powered diagnostics and data interpretation platforms. Rising Demand for Non-Invasive Biomarker Testing: Liquid biopsies present lucrative opportunities to improve patient compliance and access to early care. Collaborative Ecosystem for Companion Diagnostics: Partnerships are critical for aligning biomarker development with therapeutic innovations. Market Challenges High Cost and Limited Accessibility:Advanced biomarker testing is expensive and less accessible in underdeveloped regions. Ethical and Privacy Concerns:Genetic testing raises privacy issues and ethical concerns about data protection. Competitive Analysis Laboratory Corporation of America Holding Quest Diagnostics Incorporated Agilent Technologies, Inc. Genome Medical, Inc. Coriell Life Sciences. Roche Diagnostics NeoGenomics Laboratories FOUNDATION MEDICINE, INC. Illumina, Inc. Guardant Health PerkinElmer Bio-Rad Laboratories GE Healthcare Qiagen Thermo Fisher Scientific Inc. Europe Personalized Medicine Biomarkers Market Segmentation By Application: Diagnosis Monitoring Early Detection/Screening Treatment Selection Others By Indication: Oncology Diseases Autoimmune Diseases Cardiology Diabetes Neurology Others By Country: Germany France U.K. Italy Spain Russia Rest of Europe For more information about this report visit About is the world's leading source for international market research reports and market data. We provide you with the latest data on international and regional markets, key industries, the top companies, new products and the latest trends. CONTACT: CONTACT: Laura Wood,Senior Press Manager press@ For E.S.T Office Hours Call 1-917-300-0470 For U.S./ CAN Toll Free Call 1-800-526-8630 For GMT Office Hours Call +353-1-416-8900Error in retrieving data Sign in to access your portfolio Error in retrieving data Error in retrieving data Error in retrieving data Error in retrieving data

Discover how Dubai is using AI, design, and psychology to create public spaces that respond to mood and reshape urban living.
Discover how Dubai is using AI, design, and psychology to create public spaces that respond to mood and reshape urban living.

Hi Dubai

time16-05-2025

  • Health
  • Hi Dubai

Discover how Dubai is using AI, design, and psychology to create public spaces that respond to mood and reshape urban living.

Dubai has long been known for its skyscrapers, iconic developments, and rapid modernization, but underneath the surface of its glittering skyline lies a more subtle ambition: to build a city that understands how people feel. As global cities experiment with ways to improve quality of life through infrastructure, a growing body of research suggests that urban design isn't just functional—it's emotional. What if public spaces could reduce anxiety? What if a sidewalk could help ease your mind? These questions are at the heart of a new movement where psychology meets city planning. Around the world, urban planners and behavioral scientists are exploring how the built environment shapes emotional states. Cities like Copenhagen and Singapore are investing in emotionally responsive infrastructure design that uses light, layout, sound, and space to gently influence mood. Dubai, with its vision for futuristic living, has emerged as one of the most ambitious test beds for this idea. From AI-powered street lighting in City Walk that adapts to pedestrian flow and time of day, to green corridors and shaded walkways in the Dubai 2040 Urban Master Plan aimed at reducing daily stress, the city is increasingly framing design as a psychological tool. Public art installations under Dubai Culture's 'Art in Public Spaces' initiative are transforming metro stations into emotionally resonant spaces, while sensory-conscious buildings like Al Safa Art & Design Library offer quiet zones that prioritize mental well-being in a high-stimulation city. Can architecture influence how we feel on a daily basis? And more importantly, can a city learn to predict our moods through design alone? As Dubai moves forward with urban planning projects rooted in emotional impact, the answers to these questions are no longer speculative. In this article, we explore how public design experiments in Dubai are shaping not only the city—but the emotional experience of living in it. The Global Concept of 'Emotional Cities': Where Psychology Meets Urban Planning The idea that a city can influence—or even predict—human emotion is not a futuristic fantasy. It's a growing area of research called urban affective science, which studies how the physical structure of cities affects psychological states. In recent years, projects across Europe, North America, and Asia have turned city spaces into real-time laboratories for emotional insight. A leading example is the Emotional Cities project, a research initiative funded by the European Union's Horizon 2020 programme. Launched in 2021, it explores how urban environments impact mental health by measuring citizens' emotional responses using biometric sensors, heart rate monitors, and spatial data. The project partners with city governments and research labs to test how different parts of a city affect stress, relaxation, and focus. One of its central goals is to guide urban policy through scientifically gathered emotional data, not assumptions. Similarly, the MIT Senseable City Lab, in partnership with cities like Singapore and London, has explored how public mood can be mapped using passive data collection methods such as geolocation patterns, mobile phone usage, and social media sentiment. In one project, 'Live Singapore!', the lab created a real-time dashboard that tracked how people responded to different parts of the city using crowdsourced information. Their work shows how urban infrastructure, when paired with behavioral data, can become a mirror for public emotion. Underlying these studies is a principle called affective design—an approach that considers how light, sound, material, texture, temperature, and space affect emotional states. It's the reason many cities are experimenting with tunable street lighting, calming soundscapes, and open layouts that reduce visual clutter. This design philosophy draws from environmental psychology and neuroscience, linking specific environmental triggers to emotional reactions like calmness, joy, anxiety, or alertness. In several cities, facial expression analysis and emotion-detection algorithms have also been tested in limited pilot zones. These systems, often based on AI-driven computer vision, can identify general emotional states like stress or contentment by analyzing micro-expressions in public spaces. While still controversial due to privacy concerns, these technologies are pushing the boundaries of how urban environments might one day 'read' the mood of their users and respond accordingly. This global momentum toward emotion-aware cities creates a strong foundation for understanding Dubai's own interest in psychologically responsive design. With its technological infrastructure and fast-paced urban evolution, the city is uniquely positioned to explore how design choices—like adaptive lighting, art placement, and spatial fluidity—can influence the everyday emotional experiences of residents and visitors. Dubai's Push for Human-Centric Design: A Smart City with Emotional Intelligence Dubai's transformation into a smart city isn't solely about integrating advanced technologies; it's fundamentally about enhancing the human experience. The city's initiatives aim to create environments that not only function efficiently but also resonate emotionally with its inhabitants. The Smart Dubai 2021 strategy exemplifies this vision. Launched by the Dubai Government, it focuses on leveraging technology to improve the quality of life for residents. The strategy encompasses various sectors, including transportation, infrastructure, and urban planning, all designed to foster a more connected and responsive urban environment. Central to this human-centric approach is the Dubai Future Foundation, which spearheads innovative projects to anticipate and shape the city's future. One of its notable initiatives is the Dubai Design Lab, an action lab dedicated to reimagining and prototyping policies and systems that prioritize livability and well-being. By harnessing design and creativity, the lab seeks to position Dubai among the world's most livable cities. Incorporating artificial intelligence (AI) into urban infrastructure is another facet of Dubai's strategy. The city employs AI-driven systems to analyze data from various sources, enabling real-time responses to the needs of its citizens. For instance, AI is utilized to monitor traffic patterns and adjust signals accordingly, enhancing road safety and reducing congestion . Moreover, Dubai has implemented tools like the Happiness Meter, a city-wide initiative that captures real-time feedback on public services. This system allows residents to express their satisfaction levels, providing the government with valuable insights to improve service delivery and, by extension, the overall mood of the city. Through these integrated efforts, Dubai exemplifies how a city can evolve into a responsive entity that not only meets the functional needs of its residents but also nurtures their emotional well-being. Designing for Mood: Examples from Dubai's Public Spaces Designing for Mood: Examples from Dubai's Public Spaces Dubai's urban landscape is a testament to the city's commitment to creating environments that not only serve functional purposes but also enhance the emotional well-being of its residents and visitors. Through thoughtful integration of technology, art, and nature, Dubai's public spaces are crafted to positively influence mood and foster a sense of community. Urban Lighting and Temperature Control In areas like City Walk and Downtown Boulevard, Dubai has implemented smart lighting systems that adjust brightness and color temperature based on the time of day and pedestrian activity. These adaptive lighting solutions aim to create a comfortable and inviting atmosphere, reducing glare and enhancing visibility during nighttime hours. Such lighting not only improves safety but also contributes to a more relaxed and pleasant urban experience. Public Art Installations and Color Psychology The Dubai Metro stations have been transformed into dynamic art spaces under the "Art in Public Spaces" initiative by Dubai Culture. These installations incorporate vibrant colors and culturally significant themes, turning transit areas into engaging environments. The use of specific color palettes and artistic designs is intended to evoke positive emotions, reduce stress, and make daily commutes more enjoyable. Green Spaces and Soundscapes Developments like Al Barari, Dubai Hills, and Burj Park offer lush green environments amidst the urban setting. These areas are designed with an emphasis on natural elements, including diverse plant life and water features, to create tranquil spaces for relaxation and recreation. The presence of greenery and natural soundscapes, such as flowing water and bird songs, has been shown to reduce anxiety and promote mental restoration, providing a peaceful retreat from the city's hustle. Case Study: The Role of AI in Predicting Public Mood Dubai is at the forefront of integrating artificial intelligence (AI) into its urban infrastructure, aiming to enhance the emotional well-being of its residents through innovative technologies. The city has embarked on several initiatives that utilize AI for mood detection and emotional analysis in public spaces. Facial Recognition and AI for Mood Detection Dubai has implemented facial recognition technology in various sectors, including airports and government buildings, to streamline processes and enhance security. These systems are capable of analyzing facial expressions to detect emotions, providing insights into the public's mood. Such technologies are part of pilot projects aiming to create responsive environments that can adapt to the emotional states of individuals. Emotion-Sensing Kiosks in Government Buildings The city has introduced smart kiosks equipped with AI capabilities in government buildings. These kiosks can analyze users' facial expressions and provide services accordingly, aiming to improve user experience by responding to emotional cues. This initiative reflects Dubai's commitment to leveraging technology to enhance public services and citizen satisfaction. AI Ethics and Data Governance Frameworks Recognizing the importance of ethical considerations in AI deployment, Dubai has established comprehensive guidelines to govern the use of AI technologies. The Smart Dubai initiative has developed the Ethical AI Toolkit, which outlines principles for fairness, transparency, and accountability in AI systems. These guidelines ensure that AI applications, including those for mood detection, respect privacy and are implemented responsibly. Through these initiatives, Dubai demonstrates a proactive approach to integrating AI into urban planning, focusing on creating environments that are not only efficient but also emotionally attuned to the needs of its residents. Why Mood-Based Design Matters in a City Like Dubai Dubai's rapid transformation into a global metropolis has brought unique challenges and opportunities in urban planning, particularly concerning the emotional well-being of its residents. The city's diverse population, extreme climate, and fast-paced development necessitate a focus on mood-based design to enhance the quality of urban life. With over 80% of its population comprising expatriates from various cultural backgrounds, Dubai is a melting pot of traditions, lifestyles, and expectations. This multicultural fabric requires urban spaces that cater to a wide range of emotional and social needs. Studies have highlighted the importance of designing neighborhoods that foster social cohesion among diverse communities, emphasizing the role of physical layout and built form in promoting interactions and a sense of belonging. The city's harsh climate, characterized by soaring temperatures often exceeding 50°C in summer, significantly impacts outdoor activities and public space usage. This extreme heat can lead to increased stress levels and a preference for indoor environments, underscoring the need for climate-responsive urban design. Incorporating shaded walkways, green spaces, and cooling elements can mitigate thermal discomfort and promote outdoor engagement. Dubai's rapid urbanization and economic growth have led to high-density developments and increased traffic congestion, contributing to urban stress. The city's infrastructure must adapt to these pressures by integrating efficient public transportation, pedestrian-friendly pathways, and accessible amenities to alleviate the psychological strain associated with urban living. To address these challenges, Dubai has embraced smart city initiatives that leverage real-time data to inform urban planning. By analyzing patterns in public space usage, transportation, and environmental conditions, planners can design spaces that respond to the emotional and physical needs of residents. This data-driven approach enables the creation of adaptive environments in malls, metro stations, and parks that enhance comfort, accessibility, and overall well-being. In summary, mood-based design in Dubai is not merely an aesthetic consideration but a strategic imperative. By acknowledging and addressing the emotional impacts of its diverse population, extreme climate, and urban dynamics, the city can foster environments that promote mental health, social cohesion, and a higher quality of life for all its inhabitants. As Dubai integrates artificial intelligence (AI) into its urban infrastructure to enhance public services and citizen experiences, it faces critical ethical considerations, particularly concerning mood-based design and emotion recognition technologies. Balancing Innovation and Privacy Dubai's deployment of AI-driven facial recognition and emotion detection systems aims to improve efficiency and personalization in various sectors, including transportation, healthcare, and public services. However, these technologies raise significant privacy concerns. The collection and analysis of biometric data, such as facial expressions, necessitate stringent data protection measures to prevent misuse and unauthorized access. Ensuring that individuals are aware of and consent to the use of their biometric data is paramount to maintaining public trust. Addressing Algorithmic Bias Emotion recognition algorithms can inadvertently perpetuate biases if not properly trained on diverse datasets. For instance, variations in facial expressions across different cultures can lead to misinterpretations of emotions, resulting in unfair treatment or discrimination. It is essential to develop and continuously refine AI models to recognize and respect cultural nuances, thereby ensuring equitable outcomes for all demographic groups. Ethical Frameworks and Governance To navigate these challenges, Dubai has established comprehensive ethical guidelines for AI deployment. The Smart Dubai initiative has introduced the Ethical AI Toolkit, which outlines principles for the responsible use of AI technologies. These principles emphasize fairness, transparency, accountability, and respect for privacy. By adhering to these guidelines, developers and policymakers can ensure that AI applications align with societal values and human rights. Community Engagement and Transparency Beyond technical safeguards, fostering an open dialogue with the community is crucial. Engaging citizens in discussions about the purposes, benefits, and risks of emotion recognition technologies can lead to more informed and accepted implementations. Transparency in how data is collected, used, and protected empowers individuals and reinforces the legitimacy of AI initiatives. In conclusion, while mood-based design and emotion recognition technologies offer promising avenues for enhancing urban living in Dubai, they must be approached with a careful balance of innovation and ethical responsibility. By prioritizing privacy, addressing algorithmic biases, adhering to robust ethical frameworks, and engaging with the community, Dubai can lead in creating a smart city that respects and uplifts the emotional well-being of its residents. In a world increasingly shaped by data, the idea of a city that can read your mood is no longer science fiction—it's a matter of strategy. But while Dubai is investing in sensors, AI, and real-time feedback to better understand how people feel in public spaces, the deeper question remains: can emotion ever be fully measured, or simply acknowledged and respected? Human emotion is fluid, layered, and often unspoken. Predictive technologies might detect a frown or lowered energy in a crowd, but they can't always trace it back to its cause—was it the traffic, the heat, a lack of green space, or something far more personal? Dubai's approach suggests that even if a city can't predict mood with perfect accuracy, it can still respond with empathy. From shaded pedestrian paths and emotionally aware lighting to public art that invites reflection, the city is experimenting with ways to make urban life feel less mechanical and more mindful. And in doing so, it's introducing a new paradigm—where emotional well-being becomes a measurable design goal, not just an afterthought. So perhaps the real shift isn't in creating a city that knows exactly how you feel. It's in building one that constantly listens, adapts, and creates space for emotional connection to thrive. In this way, Dubai may not just be designing for happiness—it may be defining what it means for cities to care. Also read: Dubai Municipality Drives Major Urban Transformation with Focus on Sustainability and Smart Services Dubai Municipality is ushering in a new era of urban development, blending sustainable infrastructure, digital innovation, and community-focused services to elevate the city's livability and resilience The Future of Business in Dubai: What the 2040 Urban Master Plan Means for You Dubai has always been synonymous with progress and innovation, but with the ambitious 2040 Urban Master Plan, the city is set to transform into a global powerhouse like never before. Discover how Dubai's strategic plans will shape the future of business development in the years to come. Dubai Opens Registration for Global Self-Driving Transport Congress Dubai's Roads and Transport Authority (RTA) has officially opened registration for the fourth edition of the Dubai World Congress for Self-Driving Transport, scheduled for 24–25 September 2025. Hamdan bin Mohammed Launches Barwa Programme to Empower Senior Citizens, People of Determination in Dubai Dubai Crown Prince Sheikh Hamdan bin Mohammed bin Rashid Al Maktoum has launched the 'Barwa' programme, a pioneering initiative by the Dubai Land Department and Community Development Authority aimed at supporting senior citizens and People of Determination.

Novotech Identifies Strategic Opportunities in Idiopathic Pulmonary Fibrosis Trials with Release of Global Market Insights
Novotech Identifies Strategic Opportunities in Idiopathic Pulmonary Fibrosis Trials with Release of Global Market Insights

Business Wire

time21-04-2025

  • Health
  • Business Wire

Novotech Identifies Strategic Opportunities in Idiopathic Pulmonary Fibrosis Trials with Release of Global Market Insights

SYDNEY--(BUSINESS WIRE)--Novotech, a globally recognized full-service clinical research organization (CRO) and scientific advisory partner for biotech and small- to mid-sized pharmaceutical companies seeking to advance drug development, has released an in-depth report on the global clinical trial landscape for Idiopathic Pulmonary Fibrosis (IPF). The report offers strategic insights and comprehensive analysis critical for biotech and pharmaceutical companies navigating the complexities of IPF clinical research and drug development. Novotech, a globally recognized CRO has released an in-depth report on the global clinical trial landscape for Idiopathic Pulmonary Fibrosis. Share Advancing IPF Clinical Research: A Global Perspective Idiopathic Pulmonary Fibrosis (IPF) is a chronic, progressive lung disease characterized by the scarring of lung tissue and a steady decline in respiratory function, most commonly affecting individuals between the ages of 60 and 70. Novotech's latest report identifies more than 800 industry-sponsored IPF clinical trials launched globally since 2020, reflecting strong research momentum and a growing commitment across the biotech and pharmaceutical sectors to address the increasing burden of this serious condition. Key insights: Global Clinical Trial Activity: The Asia-Pacific region accounts for the largest share of global IPF clinical trials at 44%, primarily driven by significant activity in Mainland China. North America follows with 23%, led by the United States, while Europe contributes 21%, with notable trial concentration in the United Kingdom and Germany. Emerging Therapeutic Innovations: The development pipeline is advancing with novel therapeutic approaches, including RNA interference (RNAi)-based therapies, PDE4 inhibitors, cell-based treatments, and monoclonal antibodies—signaling promising progress in IPF management and patient outcomes. Advancements in Trial Design and Biomarkers: Precision medicine and patient-centric trial methodologies, coupled with the integration of key biomarkers, are improving diagnostic accuracy, disease monitoring, and the assessment of therapeutic efficacy in IPF studies. Investment and Funding Landscape: Strong venture capital activity is fueling early- and mid-stage IPF drug development, particularly in the United States and Europe. Public-sector contributions, including funding from the EU Horizon 2020 program and the U.S. Department of Defense, are also instrumental in supporting innovation. Addressing Racial and Ethnic Disparities: The report highlights the critical need for greater diversity in IPF clinical trials and calls for equitable care strategies and targeted education to reduce treatment disparities across racial and ethnic populations. Partnering with Novotech for IPF Clinical Trials With extensive expertise in pulmonary and respiratory diseases, Novotech offers biotech and pharmaceutical partners an accelerated path to market. The company's comprehensive capabilities include therapeutic expertise, regulatory guidance, and strategic clinical trial execution, supported by its expansive global footprint across Asia-Pacific, North America, and Europe. Download the Full Report About Novotech Novotech is a globally recognized full-service clinical research organization (CRO) and scientific advisory company trusted by biotech and small- to mid-sized pharmaceutical companies to guide drug development at every phase. With a global footprint that includes 30+ offices across the Asia-Pacific region, North America, and Europe and partnerships with 5,000+ trial sites, Novotech provides clients an accelerated path to bring life-changing therapies to market by providing access to key clinical trial destinations and diverse patient populations. Through its client-centric service model, Novotech seamlessly integrates people, processes, and technologies to deliver customized solutions that accelerate the path to market for life-changing therapies. By adopting a true partnership approach, Novotech shares a steadfast commitment to client success, empowering innovation, and advancing healthcare worldwide. Recipient of numerous industry accolades, including the Frost & Sullivan CRO Company of the Year award for 19 consecutive years, Novotech is recognized for its excellence in clinical trial execution and innovation. Its deep therapeutic and regulatory expertise, combined with local market insights, ensures streamlined clinical trials, optimized data analytics, and accelerated patient recruitment strategies. Together with clients, Novotech transforms scientific advancements into therapies that improve global health outcomes, embodying a mission of driving innovation and delivering impactful results. For more information or to speak to an expert team member, visit

Ozone Meter Market Size, Share, Trends, Opportunities, and Forecasts, 2020-2024 & 2025-2030
Ozone Meter Market Size, Share, Trends, Opportunities, and Forecasts, 2020-2024 & 2025-2030

Yahoo

time18-04-2025

  • Business
  • Yahoo

Ozone Meter Market Size, Share, Trends, Opportunities, and Forecasts, 2020-2024 & 2025-2030

Growth is fueled by rising air quality concerns and strict environmental regulations. Ozone meters, essential for tracking atmospheric ozone levels, are increasingly used in manufacturing, automotive, and agriculture sectors. Technological advancements like IoT integration and real-time monitoring enhance demand. However, the high cost of these devices remains a challenge for widespread adoption, particularly in developing regions. Key players include Aeroqual Limited, Thermo Fisher Scientific Inc., and HORIBA, Ltd. Ozone Meter Market Dublin, April 18, 2025 (GLOBE NEWSWIRE) -- The "Ozone Meter Market - Global Industry Size, Share, Trends, Opportunity, and Forecast, 2020-2030F" has been added to offering. Global Ozone Meter Market, valued at USD 1.42 billion in 2024, is projected to reach USD 2.06 billion by 2030, registering a robust CAGR of 6.2% through 2030. This growth is fueled by increasing emphasis on air quality monitoring and environmental protection as ozone pollution raises health and environmental concerns. Industries like manufacturing, automotive, agriculture, and research institutes are adopting ozone meters to comply with stringent environmental regulations. The rise in industrialization and urbanization in developing economies has spiked the demand for these devices to mitigate air pollution impacts. Continuous advancements in ozone measurement technology enhance market growth. Modern ozone meters provide improved accuracy, real-time monitoring, and portability, thanks to developments in digital sensors and IoT integration. These technological improvements make ozone meters more versatile and cost-effective for industries such as manufacturing and agriculture. Approximately 40-45% of market demand stems from environmental monitoring applications, assessing urban and rural ozone pollution impacts on climate change. However, the high cost of advanced ozone measurement devices poses a challenge. Acquisition and maintenance costs can restrict adoption, particularly in developing regions or among smaller enterprises. The need for periodic calibration and maintenance adds financial strain, potentially hindering market growth. Addressing this, manufacturers are encouraged to explore affordable solutions to increase ozone meter adoption in cost-sensitive locations. A prominent market trend is the integration of ozone meters with IoT and cloud-based platforms, enabling real-time, remote monitoring. This shift improves air quality management efficiency, offering predictive maintenance and reducing device downtime. The trend, aligned with rising demand for smart, connected devices, enhances data sharing with stakeholders, boosting regulatory compliance and decision-making. Supported by funding like the EU's Horizon 2020 program, market expansion is anticipated in manufacturing, transportation, and environmental monitoring sectors. Key Attributes: Report Attribute Details No. of Pages 181 Forecast Period 2024 - 2030 Estimated Market Value (USD) in 2024 $1.42 Billion Forecasted Market Value (USD) by 2030 $2.06 Billion Compound Annual Growth Rate 6.2% Regions Covered Global Companies Featured Aeroqual Limited Thermo Fisher Scientific Inc. HORIBA, Ltd. Teledyne Technologies Incorporated Ludlum Measurements, Inc. Lutron Electronic Enterprise Co., LTD. Micromeritics Instrument Corporation MSA Worldwide, LLC For more information about this report visit About is the world's leading source for international market research reports and market data. We provide you with the latest data on international and regional markets, key industries, the top companies, new products and the latest trends. Attachment Ozone Meter Market CONTACT: CONTACT: Laura Wood,Senior Press Manager press@ For E.S.T Office Hours Call 1-917-300-0470 For U.S./ CAN Toll Free Call 1-800-526-8630 For GMT Office Hours Call +353-1-416-8900Sign in to access your portfolio

Elypta's urine test identifies 90% of recurrent kidney cancer cases
Elypta's urine test identifies 90% of recurrent kidney cancer cases

Yahoo

time25-03-2025

  • Health
  • Yahoo

Elypta's urine test identifies 90% of recurrent kidney cancer cases

Swedish cancer diagnostic company Elypta's urine test has been able to accurately identify 90% of patients with recurrent kidney cancer. The business announced the intermediary results from its prospective multi-centre trial designed to determine if urine-collected glycosaminoglycans (GAGomes) can be used for the early detection of cancer recurrence. Specifically, following curative surgery in patients with high or intermediate risk of clear cell renal cell carcinoma (ccRCC), the most common form of kidney cancer. Elypta announced the early results as part of the 2025 European Association of Urology Congress, taking place in Madrid, Spain. The trial was co-funded by the European Union's Horizon 2020 research and innovation programme and took place at 29 international locations. The trial featured an adaptive design with primary endpoint analysis carried out after 30 events or recurrences had been reached. The company says the results underline the ability of clinicians to pivot away from the use of radiological examination for post-treatment patients, instead pushing for the use of patients' submitted urine samples as routine observation. Now, Elypta claims that the study's second patient cohort is nearing final recruitment, with validation results expected later this year. Elypta chief medical officer Volker Liebenberg said: 'A urine test can offer a less invasive and more comfortable alternative for post-operative monitoring, potentially transforming kidney cancer follow-up care.' Commenting on results from the AUR87A trial, Elypta CEO Karl Bergman said: 'These findings show the potentially transformative impact a urine-based test may have in the surveillance of recurrent disease for kidney cancer patients.' Elsewhere in the field of cancer diagnostics, Proscia has secured $50m to advance its AI-driven digital pathology platform designed to allow clinicians to interpret whole slide images. "Elypta's urine test identifies 90% of recurrent kidney cancer cases" was originally created and published by Clinical Trials Arena, a GlobalData owned brand. The information on this site has been included in good faith for general informational purposes only. It is not intended to amount to advice on which you should rely, and we give no representation, warranty or guarantee, whether express or implied as to its accuracy or completeness. You must obtain professional or specialist advice before taking, or refraining from, any action on the basis of the content on our site. Sign in to access your portfolio

DOWNLOAD THE APP

Get Started Now: Download the App

Ready to dive into the world of global news and events? Download our app today from your preferred app store and start exploring.
app-storeplay-store